LONDON (Reuters) - Clinical trials of three potential Ebola treatments will begin in December in Guinea and Liberia at medical centers run by Medecins Sans Frontieres, the medical charity said on Thursday. The separate trials, involving up to several hundred patients, are designed to test the drugs brincidofovir, from the U.S. firm Chimerix, and favipiravir, from Japan's Fujifilm, and to see how well blood plasma taken from Ebola survivors may work in curing those still infected. Initial results could be available in February 2015, MSF said in a statement. ... via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment